LGT Capital Partners’s Pediatrix Medical MD Stock Holding History

LGT Capital Partners’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-215,390	Closed	-$13M	–	66
2017 Q2	$13M	Buy	215,390 +59,650	+38%	+$3.54M	1.31%	38
2017 Q1	$10.8M	Hold	155,740	–	–	1.23%	38
2016 Q4	$10.4M	Buy	155,740 +21,200	+16%	+$1.38M	1.41%	34
2016 Q3	$8.91M	Buy	134,540 +88,540	+192%	+$6.06M	1.25%	41
2016 Q2	$3.33M	Buy	+46,000	New	+$3.16M	0.58%	52
2015 Q3	–	Sell	-3,000	Closed	-$222K	–	51
2015 Q2	$222K	Sell	3,000 -10,000	-77%	-$720K	0.06%	49
2015 Q1	$943K	Hold	13,000	–	–	0.24%	56
2014 Q4	$859K	Sell	13,000 -17,000	-57%	-$1.04M	0.22%	49
2014 Q3	$1.65M	Buy	+30,000	New	+$1.7M	0.42%	41

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

LGT Capital Partners's MD Position: Q3 2017 in Review

LGT Capital Partners sold out of Pediatrix Medical (MD) in Q3 2017, closing a stake of 215,390 shares — an estimated $13M sold.

LGT Capital Partners first reported a position in MD in Q3 2014 and held it in 9 quarters. The position peaked at $13M in Q2 2017. 337 funds tracked by Wall St. Rank hold MD as of Q3 2017.

LGT Capital Partners reported no remaining Pediatrix Medical position as of Q3 2017 after selling out during the quarter.
LGT Capital Partners sold 215,390 Pediatrix Medical shares in Q3 2017, an estimated $13M.
LGT Capital Partners first reported a position in Pediatrix Medical in Q3 2014 and held it in 9 quarters.
LGT Capital Partners's Pediatrix Medical position peaked at $13M in Q2 2017.
337 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2017.

Based on LGT Capital Partners's 13F filing for Q3 2017, filed 11 Oct 2017.